A Part of the University of Maryland Medical Center

• General Information About Mycosis Fungoides and the Sézary Syndrome
• Stages of Mycosis Fungoides and the Sézary Syndrome
• Recurrent Mycosis Fungoides and the Sézary Syndrome
• Treatment Option Overview
• Treatment Options by Stage
• Treatment Options for Recurrent Mycosis Fungoides and the Sézary Syndrome
• To Learn More About Mycosis Fungoides and the Sézary Syndrome

• Information for Patients

• Patient Care
• Being Admitted
• UMGCC Directory
• Schedule an Appointment
• Ask the Expert
• Patient Education
• Dictionary of Cancer Terms
• Cancer Topics
• Parking, Lodging and Restaurants
• 2012 Cancer Patient Event: A Day of Honor
• Podcasts
• Audio/Video Library
• 
    Related Resources
• Center for Image Renewal
• Clinical Trials
• Contact Us
• Patient Web Pages

Treatment Options for Recurrent Mycosis Fungoides and the Sézary Syndrome

Treatment of recurrent mycosis fungoides and the Sézary syndrome is usually within a clinical trial and may include the following:

• Radiation therapy to skin lesions or all the skin on the body (TSEB).
• Topical chemotherapy.
• PUVA therapy, to relieve symptoms and improve the quality of life.
• PUVA therapy with biologic therapy (interferon).
• Ultraviolet B (UVB) radiation therapy.
• Topical corticosteroid therapy, to relieve symptoms and improve the quality of life.
• Extracorporeal photochemotherapy.
• Targeted therapy with a radiolabeled monoclonal antibody.
• Targeted therapy with a monoclonal antibody (alemtuzumab or denileukin diftitox).
• Retinoid therapy.
• Chemotherapy.
• High-dose chemotherapy with stem cell transplant.
• Targeted therapy with a histone deacetylase (HDAC) inhibitor (vorinostat or romidepsin).
• A new treatment.

Check for U.S. clinical trials from NCI's list of cancer clinical trials that are now accepting patients with recurrent mycosis fungoides/Sezary syndrome. For more specific results, refine the search by using other search features, such as the location of the trial, the type of treatment, or the name of the drug. General information about clinical trials is available from the NCI Web site.